These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35719380)

  • 1. Strategies of LncRNA DLX6-AS1 on Study and Therapeutics.
    Zhao Y; Li P
    Front Genet; 2022; 13():871988. PubMed ID: 35719380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
    Ding XZ; Zhang SQ; Deng XL; Qiang JH
    Technol Cancer Res Treat; 2021; 20():1533033821990060. PubMed ID: 33550924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising long noncoding RNA DLX6-AS1 in malignant tumors.
    Xue C; Lv L; Jiang J; Li L
    Am J Transl Res; 2020; 12(12):7682-7692. PubMed ID: 33437353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
    Zhao Z; Liang S; Sun F
    Front Oncol; 2020; 10():1172. PubMed ID: 32850336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
    Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.
    Yang Q; Sun J; Ma Y; Zhao C; Song J
    Am J Transl Res; 2019; 11(11):7009-7017. PubMed ID: 31814904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p.
    Kong L; Zhang C
    Cancer Cell Int; 2020; 20():370. PubMed ID: 32774164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway.
    Liu Y; Liu X; Zhang X; Deng J; Zhang J; Xing H
    Cancer Manag Res; 2020; 12():2685-2695. PubMed ID: 32368147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.
    Zheng Q; Gu X; Yang Q; Chu Q; Dai Y; Chen Z
    Clin Chim Acta; 2021 Jun; 517():1-8. PubMed ID: 33607068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.
    Li X; Zhang H; Wu X
    Gene; 2019 Feb; 686():1-7. PubMed ID: 30366080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA.
    Hu C; Liu K; Wang B; Xu W; Lin Y; Yuan C
    Curr Pharm Des; 2021; 27(9):1211-1218. PubMed ID: 33121401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA DLX6-AS1 functions as a competing endogenous RNA for miR-577 to promote malignant development of colorectal cancer.
    Zhou FR; Pan ZP; Shen F; Huang LQ; Cui JH; Cai K; Guo XL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3742-3748. PubMed ID: 31115000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J; Liu HR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.
    Fu X; Tian Y; Kuang W; Wen S; Guo W
    Exp Ther Med; 2019 Jun; 17(6):4715-4722. PubMed ID: 31105791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
    Wu SB; Wang HQ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma.
    Li J; Li P; Zhao W; Yang R; Chen S; Bai Y; Dun S; Chen X; Du Y; Wang Y; Zang W; Zhao G; Zhang G
    Cancer Cell Int; 2015; 15():48. PubMed ID: 26052251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.